ReviewJournal of hematology & oncology2026
From tumor targeting to tumor accessibility: surface-engineered bacteria as precision living therapeutics for translational medicine.
Liyuan Qiao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.